Hims & Hers Health (HIMS) Competitors

$25.66 -1.22 (-4.52%)

As of 03:36 PM Eastern

HIMS vs. FMS, GH, BTSG, CELC, and PACS

Should you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Fresenius Medical Care AG & Co. KGaA (FMS), Guardant Health (GH), BrightSpring Health Services (BTSG), Celcuity (CELC), and PACS Group (PACS). These companies are all part of the "healthcare" industry.

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, valuation, dividends, institutional ownership, analyst recommendations, risk, earnings and profitability.

: In the previous week, Hims & Hers Health had 2 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 17 mentions for Hims & Hers Health and 15 mentions for Fresenius Medical Care AG & Co. KGaA. Hims & Hers Health's average media sentiment score of 0.73 beat Fresenius Medical Care AG & Co. KGaA's score of 0.43 indicating that Hims & Hers Health is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral
Hims & Hers Health
5 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
: Fresenius Medical Care AG & Co. KGaA has a beta of 0.81, indicating that its share price is 19% less volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.43, indicating that its share price is 143% more volatile than the S&P 500.
: Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $28.00, suggesting a potential upside of 29.04%. Hims & Hers Health has a consensus price target of $31.86, suggesting a potential upside of 25.40%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, research analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Hims & Hers Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
4 Sell rating(s)
6 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
1.60
Hims & Hers Health
1 Sell rating(s)

12 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.18
: Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hims & Hers Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA $22.20B 0.55 $1.11B $1.91 11.36
Hims & Hers Health $2.35B 2.47 $128.37M $0.51 49.81
: Hims & Hers Health has a net margin of 5.47% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.88%. Hims & Hers Health's return on equity of 22.48% beat Fresenius Medical Care AG & Co. KGaA's return on equity.
Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA 4.88% 8.96% 4.09%
Hims & Hers Health 5.47% 22.48% 7.02%
: 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Hims & Hers Health	5 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	4 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.60
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.55	$1.11B	$1.91	11.36
Hims & Hers Health	$2.35B	2.47	$128.37M	$0.51	49.81

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.88%	8.96%	4.09%
Hims & Hers Health	5.47%	22.48%	7.02%

Summary

Hims & Hers Health beats Fresenius Medical Care AG & Co. KGaA on 12 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Hims & Hers Health (NYSE:HIMS) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their media sentiment, risk, institutional ownership, analyst recommendations, dividends, valuation, earnings and profitability.

: Hims & Hers Health has a net margin of 5.47% compared to Guardant Health's net margin of -42.39%. Hims & Hers Health's return on equity of 22.48% beat Guardant Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Guardant Health -42.39% N/A -27.82%
Hims & Hers Health 5.47% 22.48% 7.02%
: Guardant Health currently has a consensus price target of $128.63, suggesting a potential upside of 41.02%. Hims & Hers Health has a consensus price target of $31.86, suggesting a potential upside of 25.40%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Hims & Hers Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
1 Hold rating(s)

19 Buy rating(s)

0 Strong Buy rating(s)
2.86
Hims & Hers Health
1 Sell rating(s)

12 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.18
: Guardant Health has a beta of 1.48, indicating that its stock price is 48% more volatile than the S&P 500. Comparatively, Hims & Hers Health has a beta of 2.43, indicating that its stock price is 143% more volatile than the S&P 500.
: In the previous week, Hims & Hers Health had 5 more articles in the media than Guardant Health. MarketBeat recorded 17 mentions for Hims & Hers Health and 12 mentions for Guardant Health. Hims & Hers Health's average media sentiment score of 0.73 beat Guardant Health's score of 0.73 indicating that Hims & Hers Health is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
6 Very Positive mention(s)
1 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
5 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
: 92.6% of Guardant Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 6.1% of Guardant Health shares are held by company insiders. Comparatively, 13.7% of Hims & Hers Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
: Hims & Hers Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Guardant Health $982.02M 12.31 -$416.28M -$3.31 N/A
Hims & Hers Health $2.35B 2.47 $128.37M $0.51 49.81

Company	Net Margins	Return on Equity	Return on Assets
Guardant Health	-42.39%	N/A	-27.82%
Hims & Hers Health	5.47%	22.48%	7.02%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Guardant Health	1 Sell rating(s)	1 Hold rating(s)	19 Buy rating(s)	0 Strong Buy rating(s)	2.86
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Guardant Health	6 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Hims & Hers Health	5 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Guardant Health	$982.02M	12.31	-$416.28M	-$3.31	N/A
Hims & Hers Health	$2.35B	2.47	$128.37M	$0.51	49.81

Summary

Hims & Hers Health beats Guardant Health on 11 of the 16 factors compared between the two stocks.

How does Hims & Hers Health compare to BrightSpring Health Services?

Hims & Hers Health (NYSE:HIMS) and BrightSpring Health Services (NASDAQ:BTSG) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

: Hims & Hers Health has a net margin of 5.47% compared to BrightSpring Health Services' net margin of 2.27%. Hims & Hers Health's return on equity of 22.48% beat BrightSpring Health Services' return on equity.
Company Net Margins Return on Equity Return on Assets
Hims & Hers Health 5.47% 22.48% 7.02%
BrightSpring Health Services 2.27% 14.63% 4.41%
: Hims & Hers Health currently has a consensus price target of $31.86, suggesting a potential upside of 25.40%. BrightSpring Health Services has a consensus price target of $56.29, suggesting a potential upside of 6.70%. Given Hims & Hers Health's higher probable upside, equities research analysts plainly believe Hims & Hers Health is more favorable than BrightSpring Health Services.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
12 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.18
BrightSpring Health Services
0 Sell rating(s)

0 Hold rating(s)

15 Buy rating(s)

2 Strong Buy rating(s)
3.12
: Hims & Hers Health has a beta of 2.43, suggesting that its share price is 143% more volatile than the S&P 500. Comparatively, BrightSpring Health Services has a beta of 1.71, suggesting that its share price is 71% more volatile than the S&P 500.
: In the previous week, BrightSpring Health Services had 9 more articles in the media than Hims & Hers Health. MarketBeat recorded 26 mentions for BrightSpring Health Services and 17 mentions for Hims & Hers Health. BrightSpring Health Services' average media sentiment score of 0.76 beat Hims & Hers Health's score of 0.73 indicating that BrightSpring Health Services is being referred to more favorably in the news media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
5 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
9 Very Positive mention(s)
3 Positive mention(s)
10 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
: 63.5% of Hims & Hers Health shares are held by institutional investors. 13.7% of Hims & Hers Health shares are held by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
: BrightSpring Health Services has higher revenue and earnings than Hims & Hers Health. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hims & Hers Health $2.35B 2.47 $128.37M $0.51 49.81
BrightSpring Health Services $12.91B 0.79 $190.67M $1.41 37.41

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	5.47%	22.48%	7.02%
BrightSpring Health Services	2.27%	14.63%	4.41%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	15 Buy rating(s)	2 Strong Buy rating(s)	3.12

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	5 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
BrightSpring Health Services	9 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.47	$128.37M	$0.51	49.81
BrightSpring Health Services	$12.91B	0.79	$190.67M	$1.41	37.41

Summary

Hims & Hers Health beats BrightSpring Health Services on 9 of the 17 factors compared between the two stocks.

How does Hims & Hers Health compare to Celcuity?

Hims & Hers Health (NYSE:HIMS) and Celcuity (NASDAQ:CELC) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

: 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 63.3% of Celcuity shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 13.3% of Celcuity shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: Hims & Hers Health has higher revenue and earnings than Celcuity. Celcuity is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hims & Hers Health $2.35B 2.47 $128.37M $0.51 49.81
Celcuity N/A N/A -$177.04M -$3.79 N/A
: Hims & Hers Health has a beta of 2.43, suggesting that its stock price is 143% more volatile than the S&P 500. Comparatively, Celcuity has a beta of 0.09, suggesting that its stock price is 91% less volatile than the S&P 500.
: Hims & Hers Health has a net margin of 5.47% compared to Celcuity's net margin of 0.00%. Hims & Hers Health's return on equity of 22.48% beat Celcuity's return on equity.
Company Net Margins Return on Equity Return on Assets
Hims & Hers Health 5.47% 22.48% 7.02%
Celcuity N/A -203.17% -52.68%
: Hims & Hers Health presently has a consensus price target of $31.86, indicating a potential upside of 25.40%. Celcuity has a consensus price target of $134.50, indicating a potential upside of 3.05%. Given Hims & Hers Health's higher probable upside, research analysts clearly believe Hims & Hers Health is more favorable than Celcuity.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
12 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.18
Celcuity
1 Sell rating(s)

1 Hold rating(s)

10 Buy rating(s)

0 Strong Buy rating(s)
2.75
: In the previous week, Celcuity had 17 more articles in the media than Hims & Hers Health. MarketBeat recorded 34 mentions for Celcuity and 17 mentions for Hims & Hers Health. Hims & Hers Health's average media sentiment score of 0.73 beat Celcuity's score of 0.33 indicating that Hims & Hers Health is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
5 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Celcuity
10 Very Positive mention(s)
3 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.47	$128.37M	$0.51	49.81
Celcuity	N/A	N/A	-$177.04M	-$3.79	N/A

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	5.47%	22.48%	7.02%
Celcuity	N/A	-203.17%	-52.68%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
Celcuity	1 Sell rating(s)	1 Hold rating(s)	10 Buy rating(s)	0 Strong Buy rating(s)	2.75

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	5 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Celcuity	10 Very Positive mention(s)	3 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Hims & Hers Health beats Celcuity on 12 of the 15 factors compared between the two stocks.

How does Hims & Hers Health compare to PACS Group?

Hims & Hers Health (NYSE:HIMS) and PACS Group (NYSE:PACS) are both mid-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, valuation, profitability, earnings, dividends and risk.

: Hims & Hers Health has a net margin of 5.47% compared to PACS Group's net margin of 3.62%. PACS Group's return on equity of 22.55% beat Hims & Hers Health's return on equity.
Company Net Margins Return on Equity Return on Assets
Hims & Hers Health 5.47% 22.48% 7.02%
PACS Group 3.62% 22.55% 3.45%
: 63.5% of Hims & Hers Health shares are owned by institutional investors. 13.7% of Hims & Hers Health shares are owned by insiders. Comparatively, 70.4% of PACS Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
: Hims & Hers Health has a beta of 2.43, suggesting that its stock price is 143% more volatile than the S&P 500. Comparatively, PACS Group has a beta of -0.03, suggesting that its stock price is 103% less volatile than the S&P 500.
: In the previous week, Hims & Hers Health had 11 more articles in the media than PACS Group. MarketBeat recorded 17 mentions for Hims & Hers Health and 6 mentions for PACS Group. Hims & Hers Health's average media sentiment score of 0.73 beat PACS Group's score of 0.13 indicating that Hims & Hers Health is being referred to more favorably in the media.
Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
5 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
: Hims & Hers Health presently has a consensus price target of $31.86, indicating a potential upside of 25.40%. PACS Group has a consensus price target of $44.40, indicating a potential upside of 34.25%. Given PACS Group's stronger consensus rating and higher probable upside, analysts clearly believe PACS Group is more favorable than Hims & Hers Health.
Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
12 Hold rating(s)

4 Buy rating(s)

0 Strong Buy rating(s)
2.18
PACS Group
0 Sell rating(s)

1 Hold rating(s)

4 Buy rating(s)

1 Strong Buy rating(s)
3.00
: PACS Group has higher revenue and earnings than Hims & Hers Health. PACS Group is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.
Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Hims & Hers Health $2.35B 2.47 $128.37M $0.51 49.81
PACS Group $5.29B 0.98 $191.54M $1.23 26.89

Company	Net Margins	Return on Equity	Return on Assets
Hims & Hers Health	5.47%	22.48%	7.02%
PACS Group	3.62%	22.55%	3.45%

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hims & Hers Health	5 Very Positive mention(s)	7 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
PACS Group	0 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hims & Hers Health	1 Sell rating(s)	12 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.18
PACS Group	0 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	3.00

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hims & Hers Health	$2.35B	2.47	$128.37M	$0.51	49.81
PACS Group	$5.29B	0.98	$191.54M	$1.23	26.89

Summary

Hims & Hers Health and PACS Group tied by winning 8 of the 16 factors compared between the two stocks.

Get Hims & Hers Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIMS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HIMS vs. The Competition

Export

Metric	Hims & Hers Health	MEDICAL INFO SYS Industry	Medical Sector	NYSE Exchange
Market Cap	$5.79B	$1.50B	$6.22B	$22.93B
Dividend Yield	N/A	N/A	2.74%	4.03%
P/E Ratio	49.79	62.00	28.48	28.49
Price / Sales	2.47	21.85	535.62	14.42
Price / Cash	31.46	24.69	43.35	25.32
Price / Book	10.67	4.83	9.94	4.60
Net Income	$128.37M	-$54.60M	$3.54B	$1.07B
7 Day Performance	-6.84%	1.52%	1.34%	0.66%
1 Month Performance	30.04%	10.18%	5.67%	6.86%
1 Year Performance	-51.21%	7.70%	42.64%	31.11%

Hims & Hers Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HIMS Hims & Hers Health	4.2342 of 5 stars	$25.67 -4.5%	$31.86 +24.1%	-45.9%	$5.84B	$2.35B	50.25	2,442	Upcoming Earnings Analyst Forecast
FMS Fresenius Medical Care AG & Co. KGaA	4.5745 of 5 stars	$22.27 -1.1%	$28.00 +25.7%	-23.3%	$12.43B	$19.63B	11.65	1,488	News Coverage Positive News Earnings Report Dividend Increase Analyst Forecast
GH Guardant Health	4.0271 of 5 stars	$80.82 -2.7%	$125.20 +54.9%	+119.7%	$10.59B	$982.02M	N/A	2,506
BTSG BrightSpring Health Services	3.6946 of 5 stars	$47.71 +0.5%	$45.50 -4.6%	+141.6%	$9.21B	$12.91B	54.16	23,500	Earnings Report Analyst Forecast
CELC Celcuity	1.5661 of 5 stars	$118.70 -1.1%	$114.33 -3.7%	+1,277.9%	$5.72B	N/A	N/A	40	Trending News Upcoming Earnings Analyst Forecast Insider Trade Analyst Revision

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HIMS) was last updated on 5/7/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Hims & Hers Health (HIMS) Competitors

HIMS vs. FMS, GH, BTSG, CELC, and PACS

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

How does Hims & Hers Health compare to Celcuity?

Summary

How does Hims & Hers Health compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Hims & Hers Health (HIMS) Competitors

HIMS vs. FMS, GH, BTSG, CELC, and PACS

How does Hims & Hers Health compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does Hims & Hers Health compare to Guardant Health?

Summary

How does Hims & Hers Health compare to BrightSpring Health Services?

Summary

How does Hims & Hers Health compare to Celcuity?

Summary

How does Hims & Hers Health compare to PACS Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HIMS vs. The Competition

Hims & Hers Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools